MRI: Non-invasive diagnostic tool for diagnosing testicular cancer

Feb 22, 2010

Researchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology.

" plays an important role in the investigation of testicular masses," said Athina C. Tsili, MD, lead author of the study. "Sonography, although the primary imaging technique for the evaluation of scrotal contents, does not always allow confident characterization of the nature of a testicular mass. The purpose of our study was to assess the role of MRI in the preoperative characterization and local staging of testicular masses," said Tsili.

Prior surgery and histological examination revealed 28 malignant and 8 benign lesions in 33 patients. "Of those 36 lesions, MRI correctly identified all 28 malignant lesions and 7/8 benign lesions," she said.

"A possible diagnosis of benign lesion based on MRI features may improve patient care and decrease the number of unnecessary surgical procedures," said Tsili.

"MRI is an efficient for the evaluation of testicular masses. It is accurate in the preoperative differentiation of benign and malignant masses, facilitating accurate estimation of the local extent of disease in patients with malignant tumors," she said.

Explore further: E-cigarettes unhelpful in smoking cessation among cancer patients

More information: www.ajronline.org

Provided by American College of Radiology / American Roentgen Ray Society

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Recommended for you

The fine line between breast cancer and normal tissues

3 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

4 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

7 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

9 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments : 0